1. Home
  2. MSPR vs CPHI Comparison

MSPR vs CPHI Comparison

Compare MSPR & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSPR
  • CPHI
  • Stock Information
  • Founded
  • MSPR 2014
  • CPHI N/A
  • Country
  • MSPR United States
  • CPHI China
  • Employees
  • MSPR N/A
  • CPHI N/A
  • Industry
  • MSPR
  • CPHI Biotechnology: Pharmaceutical Preparations
  • Sector
  • MSPR
  • CPHI Health Care
  • Exchange
  • MSPR NYSE
  • CPHI Nasdaq
  • Market Cap
  • MSPR 7.8M
  • CPHI 7.3M
  • IPO Year
  • MSPR N/A
  • CPHI N/A
  • Fundamental
  • Price
  • MSPR $1.23
  • CPHI $1.83
  • Analyst Decision
  • MSPR
  • CPHI
  • Analyst Count
  • MSPR 0
  • CPHI 0
  • Target Price
  • MSPR N/A
  • CPHI N/A
  • AVG Volume (30 Days)
  • MSPR 47.6K
  • CPHI 150.3K
  • Earning Date
  • MSPR 08-13-2025
  • CPHI 08-13-2025
  • Dividend Yield
  • MSPR N/A
  • CPHI N/A
  • EPS Growth
  • MSPR N/A
  • CPHI N/A
  • EPS
  • MSPR N/A
  • CPHI N/A
  • Revenue
  • MSPR $13,085,000.00
  • CPHI $4,295,377.00
  • Revenue This Year
  • MSPR N/A
  • CPHI N/A
  • Revenue Next Year
  • MSPR N/A
  • CPHI N/A
  • P/E Ratio
  • MSPR N/A
  • CPHI N/A
  • Revenue Growth
  • MSPR 34.74
  • CPHI N/A
  • 52 Week Low
  • MSPR $1.10
  • CPHI $1.20
  • 52 Week High
  • MSPR $13.50
  • CPHI $3.35
  • Technical
  • Relative Strength Index (RSI)
  • MSPR N/A
  • CPHI 52.11
  • Support Level
  • MSPR N/A
  • CPHI $1.55
  • Resistance Level
  • MSPR N/A
  • CPHI $1.91
  • Average True Range (ATR)
  • MSPR 0.00
  • CPHI 0.18
  • MACD
  • MSPR 0.00
  • CPHI 0.02
  • Stochastic Oscillator
  • MSPR 0.00
  • CPHI 61.38

About MSPR MSP RECOVERY INC

MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: